CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $264,622 | -19.1% | 14,227 | -44.2% | 0.08% | -42.1% |
Q3 2022 | $327,000 | +48.0% | 25,480 | -19.3% | 0.13% | +15.7% |
Q2 2022 | $221,000 | -37.0% | 31,571 | -25.4% | 0.12% | -1.7% |
Q1 2022 | $351,000 | -4.9% | 42,293 | -22.6% | 0.12% | +34.5% |
Q4 2021 | $369,000 | +27.7% | 54,618 | 0.0% | 0.09% | +26.1% |
Q3 2021 | $289,000 | -8.0% | 54,618 | 0.0% | 0.07% | +97.1% |
Q2 2021 | $314,000 | – | 54,618 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |